Literature DB >> 20668149

Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients: comment on the study by Liu et al.

Emanuela Lapice, Michele Pinelli, Gabriele Riccardi, Olga Vaccaro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20668149     DOI： 10.2337/dc10-0596

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  7 in total

Review 1.  The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.

Authors:  Tingting Li; Yun Shi; Jieyun Yin; Qin Qin; Sheng Wei; Shaofa Nie; Li Liu
Journal:  Int Urol Nephrol       Date:  2014-09-28       Impact factor: 2.370

2.  Peroxisome proliferator-activated receptor γ Pro12Ala polymorphism decrease the risk of diabetic nephropathy in type 2 diabetes: a meta analysis.

Authors:  Jiarong Ding; Chao Zhu; Xiaobin Mei; Yangyang Zhou; Bing Feng; Zhiyong Guo
Journal:  Int J Clin Exp Med       Date:  2015-05-15

3.  Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.

Authors:  Hui Zhang; Shimiao Zhu; Jing Chen; Yang Tang; Hailong Hu; Viswanathan Mohan; Radha Venkatesan; Jianmin Wang; Haiping Chen
Journal:  Diabetes Care       Date:  2012-06       Impact factor: 19.112

Review 4.  The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects.

Authors:  Lei Wang; Zan Teng; Shuang Cai; Difei Wang; Xin Zhao; Kai Yu
Journal:  Diagn Pathol       Date:  2013-07-15       Impact factor: 2.644

5.  The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.

Authors:  Emanuela Lapice; Antonella Monticelli; Sergio Cocozza; Michele Pinelli; Sara Cocozza; Dario Bruzzese; Gabriele Riccardi; Olga Vaccaro
Journal:  J Transl Med       Date:  2015-03-12       Impact factor: 5.531

6.  Prediction of the molecular mechanisms and potential therapeutic targets for diabetic nephropathy by bioinformatics methods.

Authors:  Wan-Ning Wang; Wen-Long Zhang; Guang-Yu Zhou; Fu-Zhe Ma; Tao Sun; Sen-Sen Su; Zhong-Gao Xu
Journal:  Int J Mol Med       Date:  2016-03-15       Impact factor: 4.101

7.  Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats.

Authors:  Shaohua Li; Guangbiao Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-17       Impact factor: 2.650
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.